Question

In: Biology

In 2018 a small biotech company has developed a saliva test for Alzheimer's disease, published a...

In 2018 a small biotech company has developed a saliva test for Alzheimer's disease, published a short paper in the journal of Alzheimer's disease, in which they claimed that nonsteroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen (Advil) can prevent Alzheimer's disease from progressing if the disease is detected early enough. What was the raisonning? How ever other others have suggested that that this claim is misleading, why? Can you show me your sources please.

Solutions

Expert Solution

Ans-
A team led by Canadian neuroscientist Patrick McGeer diagnose Alzheimer's disease by measuring the concentration of an amino acid called amyloid beta protein 42 (Abeta 42) which is found in everywhere in the body but made it only in our brain. They claimed that daily taking of ibuprofen may prevent the onset of Alzheimer’s disease. According to them, the production of peptide amyloid beta protein 42 (Abeta42) in most people is almost same regarding sex or age and the production rate is two to three times higher in individuals that results to develop Alzheimer’s disease. A beta 42 is deposit only in the brain and they signified that all organ made the peptide that is secreted in saliva from the submandibular gland. So, the saliva test is possible to predict whether an individual is suffering from Alzheimer’s disease.

Dr. Doug Brown, Chief Policy and Research Officer at Alzheimer’s Society inform that long-term use of Ibuprofen has the risk of stomach ulcers and intestinal bleeding and have harmful interactions with other medications like Warfarin. There is no cure for Alzheimer’s disease or dementia. Although, it can be slow down the disease’s progression by some medications. Doctors also recommend that the improving cardiovascular health, eating a healthy diet, regular exercise can delay this disease.

Patrick L. McGeer, Edith McGeer. Conquering Alzheimer’s Disease by Self Treatment. Journal of Alzheimer's Disease, 2018; 1 DOI: 10.3233/JAD-179913
https://www.nhs.uk › Behind the Headlines › Neurology
https://globalnews.ca/news/4105741/daily-ibuprofen-prevent-alzheimers/


Related Solutions

A small biotech company develops a new treatment for a rare disease. The new treatment is...
A small biotech company develops a new treatment for a rare disease. The new treatment is patented and the company is the sole monopolist in its market. The company can sell the treatment to private pharmacies and public hospitals. Pharmacies’ demand for the treatment is QPD = 84 – 0.4PP while public hospitals’ demand for the treatment is QHD = 116 – 0.6PH. The marginal cost of the new treatment is MC = 20 +2Q. The legislature passes a new...
You are a researcher at a small biotech company and your company has just obtained the...
You are a researcher at a small biotech company and your company has just obtained the license for use of a human GENOMIC DNA fragment putatively encoding a potentially novel protein, which is thought to regulate p53, the known tumor supressor protein. The scientists who originally cloned this GENE fragment HDM5 "claim" that HDM5 shares 90% DNA sequence homology with one of the HDM2 genes (refer to the review Levine & Oren, 2009). They propose that HDM5 may have HDM2-like...
You are a researcher at a small biotech company and your company has just obtained the...
You are a researcher at a small biotech company and your company has just obtained the license for use of a human GENOMIC DNA fragment putatively encoding a potentially novel protein, which is thought to regulate p53, the known tumor supressor protein. The scientists who originally cloned this GENE fragment HDM5 "claim" that HDM5 shares 90% DNA sequence homology with one of the HDM2 genes (refer to the review Levine & Oren, 2009). They propose that HDM5 may have HDM2-like...
You are a researcher at a small biotech company and your company has just obtained the...
You are a researcher at a small biotech company and your company has just obtained the license for use of a human GENOMIC DNA fragment putatively encoding a potentially novel protein, which is thought to regulate p53, the known tumor supressor protein. The scientists who originally cloned this GENE fragment HDM5 "claim" that HDM5 shares 93% DNA sequence homology with one of the HDM2 genes (refer to the review Levine & Oren, 2009). They propose that HDM5 may have HDM2-like...
The BioPharm company has developed a stress test for college-aged students. Scores on the stress test...
The BioPharm company has developed a stress test for college-aged students. Scores on the stress test are approximately normally distributed with a mean of 55 points and a standard deviation of 2 points. Scores of 58 points or higher indicate a high level of stress and are of concern to doctors. A random sample of college-aged students will be selected and each will be given this stress test. Answer the following questions based on the information given. 1. What is...
Assume there is a medical test to diagnose a disease. If a person has the disease,...
Assume there is a medical test to diagnose a disease. If a person has the disease, the probability of having positive test result is 98 percent. If a person does not have the disease, the probability of having negative test results is 99.6 percent. The probability that a person has a disease is 1 percent in the population. Answer the following questions: a) If a person has a positive test result, what is the probability that he/she has the disease?...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its customers. The company’s Marketing Department estimates that demand for the new toy will range between 15,000 units and 35,000 units per month. The new toy will sell for $3 per unit. Enough capacity exists in the company’s plant to produce 18,000 units of the toy each month. Variable expenses to manufacture and sell one unit would be $1.00, and incremental fixed expenses associated with...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its customers. The company’s Marketing Department estimates that demand for the new toy will range between 10,000 units and 40,000 units per month. The new toy will sell for $8.00 per unit. Enough capacity exists in the company’s plant to produce 15,000 units of the toy each month. Variable expenses to manufacture and sell one unit would be $4.00 , and incremental fixed expenses associated...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its customers. The company’s Marketing Department estimates that demand for the new toy will range between 20,000 units and 30,000 units per month. The new toy will sell for $9.00 per unit. Enough capacity exists in the company’s plant to produce 25,000 units of the toy each month. Variable expenses to manufacture and sell one unit would be $5.00 , and incremental fixed expenses associated...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its...
Neptune Company has developed a small inflatable toy that it is anxious to introduce to its customers. The company’s Marketing Department estimates that demand for the new toy will range between 15,000 units and 30,000 units per month. The new toy will sell for $9.00 per unit. Enough capacity exists in the company’s plant to produce 20,000 units of the toy each month. Variable expenses to manufacture and sell one unit would be $5.00 , and incremental fixed expenses associated...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT